Ardsley Advisory Partners LP Karyopharm Therapeutics Inc. Transaction History

Ardsley Advisory Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.2 - $16.95 $86,099 - $177,975	-10,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$17.03 - $21.18 $170,300 - $211,800	-10,000 Reduced 48.78%	10,500 $179,000
Q2 2018 Aug 14, 2018	BUY	$12.0 - $19.88 $246,000 - $407,540	20,500 New	20,500 $348,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $64.6M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.